1-bromo-10-chlorodecane

We are 1-bromo-10-chlorodecane CAS:28598-83-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-bromo-10-chlorodecane
CAS.NO:28598-83-6
Synonyms:1-bromo-10-chlorodecane
DECANE, 1-BROMO-10-CHLORO-
1-bromo-10-chloro-decane
1-BROMO-10-CHLORODECANE
1-Brom-10-chlordecan
Molecular Formula:28598-83-6
Molecular Weight:28598-83-6
 
Physical and Chemical Properties:
Density:28598-83-6
Melting point:-29.7ºC
Boiling point:174.2ºC
Flash point:174.2ºC
Index of Refraction:1.4102
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.0%
Moisture:≤0.3%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

1-bromo-10-chlorodecane


Related News: With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.ácido ciclopropanocarboxílico CAS:1759-53-1 “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.13096-62-3 “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.N-Benzyl-4-piperidone Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.

Related Products
Product Name
2,3-Dimercaptobutane View Details
4-methoxy-5-(3-morpholin-4-ylpropoxy)-2-nitrobenzonitrile View Details
4,4′-Bis(chloromethyl)-1,1′-biphenyl View Details
Ammonium 5-methoxy-2-methyl-4-(3-oxobutanamido)benzenesulfonate manufacturer Dimethyl suberate manufacturer pyrazine manufacturer Cyclobutanecarboxylic acid chloride manufacturer 2,3-Dichloro-5-nitropyridine manufacturer